The company was sold to an affiliate of New Enterprise Associates and a consortium of investors for $1.465 billion and ceased ...

AI-enabled clinical trial simulation company QuantHealth announced a strategic investment from Sanofi Ventures, the venture capital division of biopharmaceutical company Sanofi, bringing its total ...

The launch comes a day after General Catalyst CEO Hemant Taneja announced the closing of the firm’s $485 million acquisition of Ohio healthcare system Summa Health.

Marx Advisory CEO Ed Marx recommends that providers adopt 'AI concierge' models offering personalized treatment or watch AI-empowered patients bypass them for new self-service solutions that offer ...

With their innovative contact lens, ERG tests, which are used to diagnose hereditary retinal diseases and evaluate prognosis ...

Healthcare experts weigh in on how patients and providers will be impacted due to telehealth and hospital-at-home programs ...

The company's new offering Health Panels will allow members to schedule and view lab test results in the Oura App.

The company will use the funds to scale nationally, broaden partnerships with payers and health systems, and expand into new ...

The health system will use Abridge's platform to convert medical conversations into billable pediatric documentation.

The study claims to be the first in the world to combine AI and optogenetics in Parkinson’s diagnosis and treatment.

Thanks to the deal, Pfizer will avoid upcoming U.S. tariffs on overseas-made drugs for three years by offering discounted ...

The funds will be used to expand the company's workforce and accelerate development of its AI-powered patient engagement platform, Assort OS.